Ermium presentation at the 2023 EULAR, highlights the promise of Ermium therapeutic approach

Annegret Van der Aa, Ermium CSO/CDO, presented at EULAR 2023, European Congress of Rheumatology, held in Milano a poster entitled “Functionally selective Immunomodulator shows robust efficacy in a murine collagen-induced arthritis model”, co-authored by H. Asnagli, S. Tessier, M. Foster, S. Denies, E. Hoeben, J. P. Herbeuval, J. Crouzet, and A. Van der Aa. These results emphasize, through in vitro and in vivo results, the promise of the therapeutic approach being carried out at Ermium therapeutics.